From January 1, 2024 to March 31, 2024, the company has repurchased 312,170 shares, representing 0.29% for $298.09 million. With this, the company has completed the repurchase of 2,253,328 shares, representing 2.11% for $1,769.01 million under the buyback announced on February 3, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,006 USD | +1.27% | +4.07% | +14.53% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.53% | 107B | |
+18.72% | 123B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B | |
+86.61% | 9.19B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on February 3, 2023.